Transplant pathology

<P>Immunology </p> <p>Immune Response in Organ Transplantation</p> <p>Regulatory Immune Cells and Transplant Tolerance </p> <p>NK Cells </p> <p>Complement </p> <p>Laboratory-Based Immune Monitoring in Organ Transplantation</p> <p>HLA Testing </p> <p>Human Leukocyte Antigen System</p> <p>Histocompatibility Testing</p> <p>Transplantation and HLA</p> <p>ABO Blood Group Antigens and Transplantation</p> <p>Apheresis and Transplantation</p> <p>HLA and Transfusion</p> <p>Immunosuppressive Drugs</p> <p>Mechanism of Action of Immunosuppressive Drugs</p> <p>Therapeutic Drug Monitoring in Transplant Patients</p> <p>History of Immunosuppression Drugs in Transplantation</p> <p>Kidney Transplantation</p> <p>History of Kidney Transplantation</p> <p>Pathologic Classification of Renal Allograft Diseases</p> <p>Evaluation of the End-Stage Kidney</p> <p>Evaluation of Allograft Kidney</p> <p>Evaluation of the Donor Kidney</p> <p>Evaluation of Transplant Nephrectomy</p> <p>Evaluation of Fibrosis</p> <p>Protocol Biopsies</p> <p>Accommodation </p> <p>Tolerance </p> <p>Surgical Complications</p> <p>Acute Allograft Ischemia</p> <p>Urine Leak </p> <p>Lymphocele </p> <p>Renal Artery or Vein Thrombosis</p> <p>Transplant Renal Artery Stenosis</p> <p>Allograft Rejection</p> <p>Hyperacute Rejection</p> <p>Acute T-Cell-Mediated Rejection</p> <p>Chronic T-Cell-Mediated Rejection</p> <p>Acute Antibody-Mediated Rejection</p> <p>Chronic Antibody-Mediated Rejection</p> <p>Recurrent Diseases</p> <p>Diseases That Recur in Allografts</p> <p>De Novo Diseases</p> <p>De Novo Focal Segmental Glomerulosclerosis</p> <p>De Novo Membranous Glomerulonephritis</p> <p>Anti-GBM Disease in Alport Syndrome</p> <p>Hyperperfusion Injury</p> <p>Engraftment Syndrome</p> <p>Kidney Diseases in Nonrenal Transplant Recipients</p> <p>Graft-vs.-Host Glomerulopathies</p> <p>Drug Toxicities </p> <p>Calcineurin Inhibitor Toxicity</p> <p>mTOR Inhibitor Toxicity</p> <p>Infections </p> <p>Acute Pyelonephritis</p> <p>Polyomavirus Nephritis</p> <p>Adenovirus, Kidney</p> <p>Cytomegalovirus Infection</p> <p>Histoplasmosis</p> <p>Candidiasis </p> <p>Cryptococcosis</p> <p>Mucormycosis</p> <p>Aspergillosis </p> <p>Coccidioidomycosis</p> <p>Paracoccidioidomycosis</p> <p>Microsporidiosis</p> <p>Tuberculosis </p> <p>Malakoplakia </p> <p>Nocardiosis </p> <p>Liver Transplantation</p> <p>Pathologic Classification of Liver Allograft Diseases</p> <p>Gross Evaluation of Failed Native Liver</p> <p>Evaluation of Failed Liver Allograft</p> <p>Evaluation of the Donor Liver</p> <p>History of Liver Transplantation</p> <p>Posttransplant Surgical Complications</p> <p>Preservation Injury</p> <p>Hepatic Artery Thrombosis</p> <p>Portal Vein Thrombosis</p> <p>Bile Duct Stricture, Leak, Sludge, Biloma</p> <p>Hepatic Venous Outflow Obstruction</p> <p>Hyperperfusion Syndrome</p> <p>Allograft Rejection</p> <p>Acute Cellular Rejection, Liver</p> <p>Antibody-Mediated Rejection, Liver</p> <p>Chronic (Ductopenic) Rejection</p> <p>Recurrent Diseases In Liver Allograft</p> <p>Recurrent Hepatitis B Virus</p> <p>Recurrent Hepatitis C Virus</p> <p>Fibrosing Cholestatic HBV or HCV Hepatitis</p> <p>Recurrent Autoimmune Hepatitis</p> <p>Recurrent Primary Biliary Cholangitis</p> <p>Recurrent Primary Sclerosing Cholangitis</p> <p>Recurrent Fatty Liver Disease</p> <p>Infections </p> <p>Cytomegalovirus</p> <p>Herpes Simplex Virus</p> <p>Adenovirus, Liver</p> <p>Hepatitis E Virus</p> <p>Epstein-Barr Virus, Liver</p> <p>Fungal Infections, Liver</p> <p>Late-Graft Dysfunction</p> <p>Plasma Cell-Rich Rejection</p> <p>Graft-vs.-Host Disease, Liver</p> <p>Heart Transplantation</p> <p>Pathologic Classification of Cardiac Allograft Diseases</p> <p>Evaluation of Failed Native and Transplanted Heart</p> <p>History of Heart Transplantation</p> <p>Evaluation of Explanted Heart</p> <p>Ischemic Heart Disease</p> <p>Dilated Cardiomyopathy</p> <p>Hypertrophic Cardiomyopathy</p> <p>Congenital Heart Disease</p> <p>Sarcoidosis, Heart</p> <p>Arrhythmogenic Right Ventricular Cardiomyopathy</p> <p>Other Causes of End-Stage Heart Disease</p> <p>Allograft Rejection</p> <p>Acute Cellular Rejection, Heart</p> <p>Antibody-Mediated Rejection, Heart</p> <p>Chronic Allograft Vasculopathy, Heart</p> <p>Noninfectious Lesions</p> <p>Quilty Lesions</p> <p>Site of Previous Biopsy</p> <p>Infections </p> <p>Myocarditis </p> <p>Lung Transplantation</p> <p>Pathologic Classification of Lung Allograft Diseases</p> <p>Examination of Native and Transplanted Lungs</p> <p>History of Lung Transplantation</p> <p>Evaluation of Failed Native Lung</p> <p>Emphysema </p> <p>Cystic Fibrosis</p> <p>Idiopathic Pulmonary Fibrosis</p> <p>Connective Tissue Disease-Associated Lung Disease</p> <p>Sarcoidosis, Lung</p> <p>Pulmonary Arterial Hypertension</p> <p>Other Causes of End-Stage Lung Disease</p> <p>Surgical Complications</p> <p>Surgical Aspects and Complications, Lung</p> <p>Allograft Rejection</p> <p>Pathologic Classification of Rejection</p> <p>Antibody-Mediated Rejection, L